Metraipolis › archive › dc_d6bf545e86e6

Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2… — Europe PMC PMID:42420629

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42420629
DOI
10.1038/s41416-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-10-18T09:59:21.180Z
SHA-256 of the archived text
2060f48a9976805abdc9f668873df9e4ffc4ca3eb4d54f66885b72f660a66c5f
Stable URL of this page
https://metraipolis.com/documento/dc_d6bf545e86e6

How to cite

Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2… — Europe PMC PMID:42420629 — Europe PMC (en), https://europepmc.org/article/MED/42420629 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d6bf545e86e6 (Metraipolis archive dc_d6bf545e86e6, sha256 2060f48a9976805abdc9f668873df9e4ffc4ca3eb4d54f66885b72f660a66c5f)
BibTeX
@misc{dcd6bf545e86e6,
  title = {Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2… — Europe PMC PMID:42420629},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42420629},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d6bf545e86e6; sha256 2060f48a9976805abdc9f668873df9e4ffc4ca3eb4d54f66885b72f660a66c5f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42420629. Agents can read the archived copy with the MCP tool read_document.